Welcome to our dedicated page for Synchrony Financial SEC filings (Ticker: SYF), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Synchrony Financial filings document the regulatory record of a consumer finance company with common stock and preferred depositary shares listed on the New York Stock Exchange. Its Form 8-K reports include quarterly earnings releases, financial data supplements, presentations and monthly charge-off and delinquency statistics tied to the company’s credit portfolio.
The company’s proxy materials cover annual meeting matters, director elections, auditor ratification and advisory executive compensation votes. Other filings describe capital-structure activity, including public debt offerings under shelf registration statements, senior note indenture terms, preferred stock series and related exhibits.
Alves Paget Leonard reported acquisition or exercise transactions in this Form 4 filing.
Synchrony Financial director Paget Leonard Alves received a small compensation-related award rather than buying shares on the market. On May 15, 2026, Alves was granted 153 dividend equivalent units at an assigned value of $71.38 per unit. These units were accrued as dividends on previously granted restricted stock units and deferred stock units under Synchrony’s long-term incentive and non-employee director deferred compensation plans. Each dividend equivalent unit is economically equivalent to one share of Synchrony Financial common stock, bringing Alves’s directly held units and related share-equivalents to 51,594 following this accrual.
Richie Laurel reported acquisition or exercise transactions in this Form 4 filing.
Synchrony Financial director Laurel Richie received a grant of 135 dividend equivalent units on May 15, 2026. These units were accrued as dividends on common shares underlying previously granted restricted and deferred stock units, at an economic value of $71.38 per unit. Following this compensation-related award, Richie directly holds 50,902 units/shares-equivalent of Synchrony Financial common stock.
Issuer filed a Form 144 disclosing proposed sales of Common Stock. The notice lists specific planned dispositions tied to compensation vesting and option exercises, including 28,080, 11,920, and 11,258 shares associated with vesting or option activity on 01/21/2025, 03/01/2025, and 05/15/2026.
The filing names Fidelity Brokerage Services LLC and references NYSE as the exchange; additional numeric identifiers appear in the excerpt.
Synchrony Financial furnished monthly credit quality statistics covering the thirteen months ended April 30, 2026. For April 30, 2026, period-end loan receivables were $100.9 billion and the 30+ day delinquency rate was 4.3%.
The reported net charge-off rate was 5.5%, with a recovery adjustment of 0.1%, resulting in an adjusted net charge-off rate of 5.6%. The company defines this adjusted net charge-off measure as non-GAAP and believes it better reflects quarterly and annual loss trends. These credit metrics will continue to be furnished monthly, with quarter-end months released alongside quarterly results.
Capital World Investors reports beneficial ownership of 33,796,907 shares of Synchrony Financial common stock, representing 9.7% of the class. The filing states the figure is based on 347,596,279 shares believed outstanding as of 03/31/2026. The disclosure lists sole voting and dispositive power over all 33,796,907 shares and identifies Capital World Investors as an investment management division of Capital Research and Management Company and affiliated entities.
Synchrony Financial officer Curtis Howse reported an open-market sale of 8,436 shares of Synchrony Financial common stock on May 1, 2026 at $76.55 per share. The sale was made under a pre-arranged Rule 10b5-1 trading plan adopted on July 24, 2025. After this transaction, Howse directly holds 86,437 shares of Synchrony Financial common stock.
Synchrony Financial director Arthur W. Coviello Jr. reported an open-market sale of 4,000 shares of Common Stock at an average price of $76.55 per share. After this transaction, he directly holds 29,341 shares. The sale was executed under a pre-arranged Rule 10b5-1 trading plan adopted on July 25, 2025, indicating the trade was scheduled in advance.
Synchrony Financial officer Alberto Casellas exercised stock options and sold the resulting shares in a planned trade. On May 1, he exercised options to acquire 5,794 shares of common stock at $34.30 per share, then sold 5,794 shares in an open‑market transaction at $76.55 per share.
The filing shows these transactions were executed under a pre‑arranged Rule 10b5‑1 trading plan adopted on October 27, 2025. Following the sale, Casellas directly holds 50,331 shares of Synchrony common stock, and the 2017 option grant for 11,588 shares has been fully exercised.
Form 144 filings list proposed sales of common stock by brokers and an individual. The excerpt shows a broker sale entry of 5,794 shares scheduled 05/01/2026 tied to options granted 04/01/2017 and two reported dispositions by Alberto B. Casellas: 41,514 shares on 02/17/2026 and 14,399 shares on 03/02/2026, each with an associated cash amount.
Form 144 notice: A Form 144 filing reports the proposed sale of 4,000 shares of Common Stock, scheduled on 02/02/2026. The filing shows a reported sale by Arthur W. Coviello Jr. for $289,280.00. The broker listed is Raymond James & Associates.